TAIWAN · TWSE / TPEx
H2 INC.
慧康生技*-KY · 7851 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-19NT$30.951 month +37.6% · 1 year —
Directors and supervisors hold14,021,89520.7% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold7,522,30911.1% of shares issued
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 鄧居義 | Chairman · President · Major shareholder (10%+) | 7,606,326 | 7,522,309 | 11.11% | — | 3,100,000 |
| 陳主望 | Director | — | 22,350 | 0.03% | — | 1,218,124 |
| 高英聰 | Director | 48,000 | 48,000 | 0.07% | — | — |
| WI Harper Fund VIII LP | Director | 1,038,312 | 1,038,312 | 1.53% | — | — |
| 劉宏祥 | Director (corporate representative) | — | 0 | — | — | — |
| Cherubic Capital Inc. | Director | 1,566,552 | 1,478,552 | 2.18% | — | — |
| 成之璇 | Director (corporate representative) | — | 0 | — | — | — |
| 台杉水牛三號生技創投有限合夥 | Director | 3,912,372 | 3,912,372 | 5.78% | — | — |
| 林世永 | Director (corporate representative) | — | 0 | — | — | — |
| 汪林麗珠 | Independent director | — | 0 | — | — | — |
| 何啟功 | Independent director | — | 0 | — | — | — |
| 吳毅明 | Independent director | — | 0 | — | — | — |
| 賴致光 | Vice president | — | 2,231,576 | 3.30% | — | — |
| 鍾文君 | Vice president | — | 646,441 | 0.95% | — | — |
| 黃智霖 | Vice president | — | 47,840 | 0.07% | — | — |
| 趙晨浩 | Chief financial officer · Chief accountant · Other | — | 16,480 | 0.02% | — | — |
| Yuji Nomoto | Other | — | 4,605,155 | 6.80% | — | — |
| 吳純誼 | Other | — | 1,440 | 0.00% | — | — |